News

Telehealth and Telecare Aware20h
23andMe sold to Regeneron for $256M in court-supervised bankruptcy, sans Lemonaid. And is it worth it?
Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...
Opinion
Telehealth and Telecare Aware6dOpinion
Short takes: Synchron BCI integrates with Apple devices, Shields Health partners with Duke on specialty pharmacy, raises for Cohere Health, Olio
The Synchron Stentrode device is still in clinical trials and has been in development since 2012. Synchron achieved the first BCI in 2019. In March, they and NVIDIA announced Chiral, a foundation ...